MYND Life Sciences Inc. Stock OTC Markets
Equities
MYNDF
CA62857B1094
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0249 USD | +17.45% | 0.00% | -20.19% |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 717K |
---|---|---|---|---|---|
Net income 2022 | -3M | Net income 2023 | -1M | EV / Sales 2022 | - |
Net Debt 2022 | 2.59 | Net Debt 2023 | 3 | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.05
x | P/E ratio 2023 |
-0.47
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.17% |
1 day | +17.45% | ||
Current month | +9.69% | ||
1 month | +9.69% | ||
3 months | -3.11% | ||
6 months | +24.50% | ||
Current year | -20.19% |
Managers | Title | Age | Since |
---|---|---|---|
John Campbell
CEO | Chief Executive Officer | 53 | 20-11-25 |
Lyle Oberg
FOU | Founder | 63 | 18-07-05 |
Founder | 65 | 18-07-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 65 | 18-07-05 | |
Lyle Oberg
FOU | Founder | 63 | 18-07-05 |
John Campbell
CEO | Chief Executive Officer | 53 | 20-11-25 |
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- MYND Stock
- MYNDF Stock